DiaSorin S.p.A (DIA) - Medical Equipment - Deals and Alliances Profile

Date: July 21, 2016
Pages: 51
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: D07C9132E3FEN
Leaflet:

Download PDF Leaflet

DiaSorin S.p.A (DIA) - Medical Equipment - Deals and Alliances Profile
Summary

DiaSorin S.p.A. (DiaSorin) is a medical diagnostics company that develops, manufactures and markets in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Radioimmunometry (RIA), Enzyme Linked Immunosorbent Assays (ELISA) and Chemiluminescence (CLIA) techniques, to enable automatic diagnostic investigation. The company’s products find application in the diagnosis of infectious diseases, bone and mineral disorders, endocrinology, hypertension, oncology, gastrointestinal infections, autoimmune disorders, and neurological and cardiac diseases. DiaSorin markets its products through direct sales force and distributors. It has operations in North America, South America, South Africa, EMEA and Asia. DiaSorin is headquartered at Saluggia, Piemonte, Italy.

DiaSorin S.p.A (DIA) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
DiaSorin S.p.A, Medical Equipment, Deals By Year, 2010 to YTD 2016
DiaSorin S.p.A, Medical Equipment Deals By Type, 2010 to YTD 2016
DiaSorin S.p.A, Medical Equipment, Deals By Region, 2010 to YTD 2016
DiaSorin S.p.A, Medical Equipment, Deals By Market, 2010 to YTD 2016
DiaSorin S.p.A, Medical Equipment, Deals Summary, 2010 to YTD 2016
DiaSorin S.p.A, Medical Equipment, Deal Details
Asset Purchase
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics
Biotrin International Acquires Molecular Diagnostic Business Of NorDiag For US$10 Million
Partnerships
AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies
DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics
Enzo Clinical Enters Into Collaboration Agreement With DiaSorin
DiaSorin Forms Joint Venture With Trivitron Healthcare
DiaSorin Extends Distribution Agreement With Cardinal Health for Lab Instruments And Immunoassay Kits
Precision System Science Enters Into Co-Development Agreement With Biotrin International
Meridian Bioscience Enters Into An Agreement With DiaSorin
Piramal Healthcare Terminates Its Distribution Agreement With DiaSorin
DiaSorin S.p.A - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Strategy And Business Planning
May 12, 2015: DiaSorin presents the 2015-2017 industrial plan
Financial Announcements
Nov 11, 2015: DiaSorin Group reports growth in revenues and profitability in the third quarter 2015 and raises guidance on revenues and Ebitda for 2015
Jul 30, 2015: DiaSorin: H1'15 Results
May 12, 2015: DiaSorin: The Board of Directors approves the results for Q1'15
Apr 22, 2015: Diasorin: The ordinary shareho lders’ meeting approves the 2014 statutory financial statements, the dividend distribution and resolves favorably upon the compensation report
Mar 03, 2015: The Board of Directors approves the results for FY'14
Legal and Regulatory
Jun 03, 2015: NICE issues final diagnostics guidance on prostate cancer tests and consults on draft guidance on tests for bacterial infection and skin cancer
Product News
Dec 08, 2015: Kyowa Medex Launched 'Liaison 25 -hydroxyvitamin D Total' in Japan
May 28, 2015: Diasorin Completes CLIA Panel Of Bacterial Gastrointesinal Infections, With The Launch Of Campylobacter
Apr 14, 2015: Diasorin Launches New Test For The Quantitative Determination Of IgA antibodies to Bordetella Pertussis On Its Liaison Xl Platform
Apr 14, 2015: Diasorin Launches New Test For The Quantitative Determination Of IgG antibodies to Bordetella Pertussis On Its Liaison Xl Platform
Jan 14, 2015: DiaSorin Launches The Test For Calprotectin For Stool Testing
Other Significant Developments
Jul 20, 2015: Diasorin And Beckman Coulter Sign A Distribution Partnership For Hepatitis And Hiv Tests In China
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

DiaSorin S.p.A, Medical Equipment, Key Facts, 2015
DiaSorin S.p.A, Medical Equipment, Deals Summary, 2010 to YTD 2016
DiaSorin S.p.A, Medical Equipment, Deals By Year, 2010 to YTD 2016
DiaSorin S.p.A, Medical Equipment Deals By Type, 2010 to YTD 2016
DiaSorin S.p.A, Medical Equipment, Deals By Region, 2010 to YTD 2016
DiaSorin S.p.A, Deals By Market, 2010 to YTD 2016
DiaSorin S.p.A, Medical Equipment, Deals Summary, 2010 to YTD 2016
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics
Biotrin International Acquires Molecular Diagnostic Business Of NorDiag For US$10 Million
AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies
DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics
Enzo Clinical Enters Into Collaboration Agreement With DiaSorin
DiaSorin Forms Joint Venture With Trivitron Healthcare
DiaSorin Extends Distribution Agreement With Cardinal Health for Lab Instruments And Immunoassay Kits
Precision System Science Enters Into Co-Development Agreement With Biotrin International
Meridian Bioscience Enters Into An Agreement With DiaSorin
Piramal Healthcare Terminates Its Distribution Agreement With DiaSorin
DiaSorin S.p.A, Key Competitors
DiaSorin S.p.A, Key Employees
DiaSorin S.p.A, Subsidiaries

LIST OF FIGURES

DiaSorin S.p.A, Medical Equipment, Deals by Type, 2010 to YTD 2016
DiaSorin S.p.A, Medical Equipment, Deals By Year, 2010 to YTD 2016
DiaSorin S.p.A, Medical Equipment, Deals By Region, 2010 to YTD 2016
DiaSorin S.p.A, Medical Equipment, Deals By Market, 2010 to YTD 2016
DiaSorin S.p.A, Medical Equipment, Deals By Year, 2010 to YTD 2016
DiaSorin S.p.A, Medical Equipment, Deals by Type, 2010 to YTD 2016
DiaSorin S.p.A, Medical Equipment, Deals By Region, 2010 to YTD 2016
DiaSorin S.p.A, Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

DiaSorin S.p.A (DIA) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: